Apatinib inhibits tumor progression and promotes antitumor efficacy of cytotoxic drugs in esophageal squamous cell carcinoma.

被引：0
作者：
Chi, Yanyan
Wang, Feng
Meng, Xiangrui
Shan, Zhengzheng
Sun, Yan
Fan, Qingxia
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15554
引用
收藏
页数：1
相关论文
共 50 条
[41]   Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma [J].
Jian Zhao ;
Junmei Lei ;
Junyan Yu ;
Chengyan Zhang ;
Xuefeng Song ;
Ninggang Zhang ;
Yusheng Wang ;
Suxiang Zhang .
Investigational New Drugs, 2020, 38 :500-506
[42]   Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma [J].
Zhao, Jian ;
Lei, Junmei ;
Yu, Junyan ;
Zhang, Chengyan ;
Song, Xuefeng ;
Zhang, Ninggang ;
Wang, Yusheng ;
Zhang, Suxiang .
INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) :500-506
[43]   Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report [J].
Yuan-Yuan Qiao ;
Kai-Xuan Lin ;
Ze Zhang ;
Da-Jin Zhang ;
Cheng-He Shi ;
Ming Xiong ;
Xiu-Hua Qu ;
Xiao-Hang Zhao .
World Journal of Gastroenterology, 2015, 21 (25) :7921-7928
[44]   Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report [J].
Qiao, Yuan-Yuan ;
Lin, Kai-Xuan ;
Zhang, Ze ;
Zhang, Da-Jin ;
Shi, Cheng-He ;
Xiong, Ming ;
Qu, Xiu-Hua ;
Zhao, Xiao-Hang .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (25) :7921-7928
[45]   Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression [J].
Chen, Liping ;
Zhu, Shihao ;
Liu, Tianyuan ;
Zhao, Xuan ;
Xiang, Tao ;
Hu, Xiao ;
Wu, Chen ;
Lin, Dongxin .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
[46]   Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression [J].
Liping Chen ;
Shihao Zhu ;
Tianyuan Liu ;
Xuan Zhao ;
Tao Xiang ;
Xiao Hu ;
Chen Wu ;
Dongxin Lin .
Signal Transduction and Targeted Therapy, 8
[47]   The role of NADPH oxidase 2 in tumor progression of esophageal squamous cell carcinoma [J].
Shimizu, Hiroki ;
Shiozaki, Atsushi ;
Katsurahara, Keita ;
Inoue, Hiroyuki ;
Kosuga, Toshiyuki ;
Kudou, Michihiro ;
Arita, Tomohiro ;
Konishi, Hirotaka ;
Komatsu, Shuhei ;
Fujiwara, Hitoshi ;
Otsuji, Eigo .
CANCER SCIENCE, 2023, 114 :619-619
[48]   Cytoskeletal protein Flightless I inhibits apoptosis, enhances tumor cell invasion and promotes cutaneous squamous cell carcinoma progression [J].
Kopecki, Zlatko ;
Yang, Gink N. ;
Jackson, Jessica E. ;
Melville, Elizabeth L. ;
Caley, Matthew P. ;
Murrell, Dedee F. ;
Darby, Ian A. ;
O'Toole, Edel A. ;
Samuel, Michael S. ;
Cowin, Allison J. .
ONCOTARGET, 2015, 6 (34) :36426-36440
[49]   miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma [J].
Mao, Yu ;
Liu, Jia ;
Zhang, Dakai ;
Li, Baosheng .
TUMOR BIOLOGY, 2016, 37 (07) :9009-9022
[50]   FGF19 promotes esophageal squamous cell carcinoma progression by inhibiting autophagy [J].
Ying, L. ;
Huang, M. ;
Jin, J. ;
Wu, Y. ;
Su, D. .
ANNALS OF ONCOLOGY, 2019, 30
12345